143 related articles for article (PubMed ID: 35171337)
1. SARS-CoV-2-related mortality and treatment delays for cancer patients in Austria : Findings of a multicentric nationwide study.
Berger JM; Wohlfarth P; Königsbrügge O; Knaus HA; Porpaczy E; Kaufmann H; Schreiber J; Mrva-Ghukasyan T; Winder T; Severgnini L; Wolf D; Petzer V; Nguyen VA; Weinlich G; Öhler L; Wonnerth A; Miksovsky A; Engelhart B; Preusser M; Berghoff AS
Wien Klin Wochenschr; 2022 May; 134(9-10):371-376. PubMed ID: 35171337
[TBL] [Abstract][Full Text] [Related]
2. Safety of systemic anti-cancer treatment in oncology patients with non-severe COVID-19: a cohort study.
van Marcke C; Honoré N; van der Elst A; Beyaert S; Derouane F; Dumont C; Aboubakar Nana F; Baurain JF; Borbath I; Collard P; Cornélis F; De Cuyper A; Duhoux FP; Filleul B; Galot R; Gizzi M; Mazzeo F; Pieters T; Seront E; Sinapi I; Van den Eynde M; Whenham N; Yombi JC; Scohy A; van Maanen A; Machiels JP
BMC Cancer; 2021 May; 21(1):578. PubMed ID: 34016086
[TBL] [Abstract][Full Text] [Related]
3. The impact of COVID-19 on liver transplantation programs in Austria.
Hartl L; Tatscher E; Weiss M; Balcar L; Strassl R; Jachs M; Mandorfer M; Soliman T; Stadlbauer V; Schemmer P; Berlakovich G; Tilg H; Schneeberger S; Trauner M; Fickert P; Reiberger T; Graziadei I
Wien Klin Wochenschr; 2022 Dec; 134(23-24):875-882. PubMed ID: 36369363
[TBL] [Abstract][Full Text] [Related]
4. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
[TBL] [Abstract][Full Text] [Related]
5. Severity and 1-month outcome of SARS-CoV-2 infection in patients with solid cancers: a Danish nationwide cohort study.
Ehmsen S; Jakobsen LH; Lendorf ME; Eefsen RL; Bentsen L; Knoop AS; Aggerholm-Pedersen N; Skuladottir H; Herrstedt J; Jensen LH; Rotbøl C; Damm MB; Wedervang K; Glenthøj A; Ryg J; Frederiksen H; Kodahl AR
Acta Oncol; 2021 Jul; 60(7):859-865. PubMed ID: 33646071
[TBL] [Abstract][Full Text] [Related]
6. COVID-19 in patients with cancer: first report of the ESMO international, registry-based, cohort study (ESMO-CoCARE).
Castelo-Branco L; Tsourti Z; Gennatas S; Rogado J; Sekacheva M; Viñal D; Lee R; Croitoru A; Vitorino M; Khallaf S; Šušnjar S; Soewoto W; Cardeña A; Djerouni M; Rossi M; Alonso-Gordoa T; Ngelangel C; Whisenant JG; Choueiri TK; Dimopoulou G; Pradervand S; Arnold D; Harrington K; Michielin O; Dafni U; Pentheroudakis G; Peters S; Romano E
ESMO Open; 2022 Jun; 7(3):100499. PubMed ID: 35644101
[TBL] [Abstract][Full Text] [Related]
7. SARS-CoV-2 screening in cancer outpatients during the second wave of the COVID-19 pandemic : Conclusions for crisis response at a high-volume oncology center.
Berger JM; Gansterer M; Trutschnig W; Bathke AC; Strassl R; Lamm W; Raderer M; Preusser M; Berghoff AS
Wien Klin Wochenschr; 2021 Sep; 133(17-18):909-914. PubMed ID: 34410467
[TBL] [Abstract][Full Text] [Related]
8. Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium.
Grivas P; Khaki AR; Wise-Draper TM; French B; Hennessy C; Hsu CY; Shyr Y; Li X; Choueiri TK; Painter CA; Peters S; Rini BI; Thompson MA; Mishra S; Rivera DR; Acoba JD; Abidi MZ; Bakouny Z; Bashir B; Bekaii-Saab T; Berg S; Bernicker EH; Bilen MA; Bindal P; Bishnoi R; Bouganim N; Bowles DW; Cabal A; Caimi PF; Chism DD; Crowell J; Curran C; Desai A; Dixon B; Doroshow DB; Durbin EB; Elkrief A; Farmakiotis D; Fazio A; Fecher LA; Flora DB; Friese CR; Fu J; Gadgeel SM; Galsky MD; Gill DM; Glover MJ; Goyal S; Grover P; Gulati S; Gupta S; Halabi S; Halfdanarson TR; Halmos B; Hausrath DJ; Hawley JE; Hsu E; Huynh-Le M; Hwang C; Jani C; Jayaraj A; Johnson DB; Kasi A; Khan H; Koshkin VS; Kuderer NM; Kwon DH; Lammers PE; Li A; Loaiza-Bonilla A; Low CA; Lustberg MB; Lyman GH; McKay RR; McNair C; Menon H; Mesa RA; Mico V; Mundt D; Nagaraj G; Nakasone ES; Nakayama J; Nizam A; Nock NL; Park C; Patel JM; Patel KG; Peddi P; Pennell NA; Piper-Vallillo AJ; Puc M; Ravindranathan D; Reeves ME; Reuben DY; Rosenstein L; Rosovsky RP; Rubinstein SM; Salazar M; Schmidt AL; Schwartz GK; Shah MR; Shah SA; Shah C; Shaya JA; Singh SRK; Smits M; Stockerl-Goldstein KE; Stover DG; Streckfuss M; Subbiah S; Tachiki L; Tadesse E; Thakkar A; Tucker MD; Verma AK; Vinh DC; Weiss M; Wu JT; Wulff-Burchfield E; Xie Z; Yu PP; Zhang T; Zhou AY; Zhu H; Zubiri L; Shah DP; Warner JL; Lopes G
Ann Oncol; 2021 Jun; 32(6):787-800. PubMed ID: 33746047
[TBL] [Abstract][Full Text] [Related]
9. Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial.
Cuadrado-Lavín A; Olmos JM; Cifrian JM; Gimenez T; Gandarillas MA; García-Saiz M; Rebollo MH; Martínez-Taboada V; López-Hoyos M; Fariñas MC; Crespo J
Trials; 2020 Jun; 21(1):472. PubMed ID: 32493494
[TBL] [Abstract][Full Text] [Related]
10. Impact of SARS-CoV-2 in Hematopoietic Stem Cell Transplantation and Chimeric Antigen Receptor T Cell Therapy Recipients.
Mushtaq MU; Shahzad M; Chaudhary SG; Luder M; Ahmed N; Abdelhakim H; Bansal R; Balusu R; DeJarnette S; Divine C; Kribs R; Shune L; Singh AK; Ganguly S; Abhyankar SH; McGuirk JP
Transplant Cell Ther; 2021 Sep; 27(9):796.e1-796.e7. PubMed ID: 34256172
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for Coronavirus Disease 2019 (COVID-19) severity and mortality among solid cancer patients and impact of the disease on anticancer treatment: A French nationwide cohort study (GCO-002 CACOVID-19).
Lièvre A; Turpin A; Ray-Coquard I; Le Malicot K; Thariat J; Ahle G; Neuzillet C; Paoletti X; Bouché O; Aldabbagh K; Michel P; Debieuvre D; Canellas A; Wislez M; Laurent L; Mabro M; Colle R; Hardy-Bessard AC; Mansi L; Colomba E; Bourhis J; Gorphe P; Pointreau Y; Idbaih A; Ursu R; Di Stefano AL; Zalcman G; Aparicio T;
Eur J Cancer; 2020 Dec; 141():62-81. PubMed ID: 33129039
[TBL] [Abstract][Full Text] [Related]
12. Measures of infection prevention and incidence of SARS-CoV-2 infections in cancer patients undergoing radiotherapy in Germany, Austria and Switzerland.
Matuschek C; Fischer JC; Combs SE; Fietkau R; Corradini S; Zänker K; Bölke E; Djiepmo-Njanang FJ; Tamaskovics B; Fischer JE; Stuschke M; Pöttgen C; Förster R; Zwahlen DR; Papachristofilou A; Ganswindt U; Pelka R; Schneider EM; Feldt T; Jensen BEO; Häussinger D; Knoefel WT; Kindgen-Milles D; Pedoto A; Grebe O; van Griensven M; Budach W; Haussmann J
Strahlenther Onkol; 2020 Dec; 196(12):1068-1079. PubMed ID: 32914236
[TBL] [Abstract][Full Text] [Related]
13. High mortality rate in cancer patients with symptoms of COVID-19 with or without detectable SARS-COV-2 on RT-PCR.
Assaad S; Avrillon V; Fournier ML; Mastroianni B; Russias B; Swalduz A; Cassier P; Eberst L; Steineur MP; Kazes M; Perol M; Michallet AS; Rey P; Erena-Penet AS; Morel A; Brahmi M; Dufresne A; Tredan O; Chvetzoff G; Fayette J; de la Fouchardiere C; Ray-Coquard I; Bachelot T; Saintigny P; Tabutin M; Dupré A; Nicolas-Virelizier E; Belhabri A; Roux PE; Fuhrmann C; Pilleul F; Basle A; Bouhamama A; Galvez C; Herr AL; Gautier J; Chabaud S; Zrounba P; Perol D; Blay JY
Eur J Cancer; 2020 Aug; 135():251-259. PubMed ID: 32540204
[TBL] [Abstract][Full Text] [Related]
14. SARS-CoV-2 re-infection risk in Austria.
Pilz S; Chakeri A; Ioannidis JP; Richter L; Theiler-Schwetz V; Trummer C; Krause R; Allerberger F
Eur J Clin Invest; 2021 Apr; 51(4):e13520. PubMed ID: 33583018
[TBL] [Abstract][Full Text] [Related]
15. SARS-CoV-2 infection in the first trimester and the risk of early miscarriage: a UK population-based prospective cohort study of 3041 pregnancies conceived during the pandemic.
Balachandren N; Davies MC; Hall JA; Stephenson JM; David AL; Barrett G; O'Neill HC; Ploubidis GB; Yasmin E; Mavrelos D
Hum Reprod; 2022 May; 37(6):1126-1133. PubMed ID: 35389480
[TBL] [Abstract][Full Text] [Related]
16. COVID-19 Outcomes Among Patients With Cancer: Observations From the University of California Cancer Consortium COVID-19 Project Outcomes Registry.
Borno HT; Kim MO; Hong JC; Yousefi S; Lin A; Tolstykh I; Zhang S; McKay RR; Harismendy O; Cinar P; Rugo H; Koshkin VS; Rabow M; Wang C; Bailey A; Small EJ
Oncologist; 2022 May; 27(5):398-406. PubMed ID: 35348771
[TBL] [Abstract][Full Text] [Related]
17. A Reminder of Skin Cancer During the COVID-19 Pandemic.
Šitum M; Filipović N; Buljan M
Acta Dermatovenerol Croat; 2021 Apr; 291(1):58. PubMed ID: 34477068
[TBL] [Abstract][Full Text] [Related]
18. Clinical characteristics, outcomes, and risk factors for mortality in patients with cancer and COVID-19 in Hubei, China: a multicentre, retrospective, cohort study.
Yang K; Sheng Y; Huang C; Jin Y; Xiong N; Jiang K; Lu H; Liu J; Yang J; Dong Y; Pan D; Shu C; Li J; Wei J; Huang Y; Peng L; Wu M; Zhang R; Wu B; Li Y; Cai L; Li G; Zhang T; Wu G
Lancet Oncol; 2020 Jul; 21(7):904-913. PubMed ID: 32479787
[TBL] [Abstract][Full Text] [Related]
19. Defining the true impact of coronavirus disease 2019 in the at-risk population of patients with cancer.
Angelis V; Tippu Z; Joshi K; Reis S; Gronthoud F; Fribbens C; Okines A; Stanway S; Cottier E; McGrath S; Watkins D; Noble J; Bhosle J; Gerlinger M; Hamid I; Soliman H; Nenclares P; Jones R; Harrington K; Gennatas S
Eur J Cancer; 2020 Sep; 136():99-106. PubMed ID: 32659475
[TBL] [Abstract][Full Text] [Related]
20. Evaluating the Association of Clinical Characteristics With Neutralizing Antibody Levels in Patients Who Have Recovered From Mild COVID-19 in Shanghai, China.
Wu F; Liu M; Wang A; Lu L; Wang Q; Gu C; Chen J; Wu Y; Xia S; Ling Y; Zhang Y; Xun J; Zhang R; Xie Y; Jiang S; Zhu T; Lu H; Wen Y; Huang J
JAMA Intern Med; 2020 Oct; 180(10):1356-1362. PubMed ID: 32808970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
